TANDEM DIABETES CARE INC

By person

17 insiders · 2 transactions

4.6×

John Sheridan holds only 4.6 times base salary in stock. $3.69M of shares against $790.58K in salary for 2025.

Salary from the company's own proxy. The shares are what John Sheridan last reported holding, valued at $23.05, the price Common Stock was last bought or sold at on the open market here, on 17 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Novara Mark David

EVP & CHIEF COMMERCIAL OFFICER

—

$4.36K (2)

−$4.36K

40,317

0.0579%

$929.31K

—

BLICKENSTAFF KIM D

Director

—

165,190

0.2374%

$3.81M

−19.5%

Sheridan John F

PRESIDENT & CEO

—

160,260

0.2303%

$3.69M

+222.0%

Vosseller Leigh

EVP & CHIEF FINANCIAL OFFICER

—

77,620

0.1116%

$1.79M

+142.1%

Morrison Susan

EVP & Chief Admin. Officer

—

52,788

0.0759%

$1.22M

+125.9%

Gasser Elizabeth Anne

EVP, Chief Strategy Officer

—

34,505

0.0496%

$795.34K

+162.9%

Carpenter Rick

EVP & Chief Technology Officer

—

32,148

0.0462%

$741.01K

+151.1%

Hansen Shannon Marie

EVP & Chief Legal Officer

—

31,650

0.0455%

$729.53K

+227.0%

Kyrillos Jean-Claude

EVP & Chief Operating Officer

—

30,290

0.0435%

$698.18K

—

Howell Peyton R

Director

—

29,836

0.0429%

$687.72K

+78.8%

Allen Dick

Chair Emeritus

—

28,146

0.0405%

$648.77K

+75.9%

McGroddy-Goetz Kathleen

Director

—

26,612

0.0382%

$613.41K

+97.6%

TWOMEY CHRISTOPHER J

Director

—

24,434

0.0351%

$563.20K

+116.5%

Sodhi Rajwant

Director

—

24,280

0.0349%

$559.65K

+118.1%

ROBERTSON REBECCA B

Director

—

22,542

0.0324%

$519.59K

+139.9%

Malagueira Joao Paulo Falcao

Director

—

22,458

0.0323%

$517.66K

+196.9%

Cha Myoungil

Director

—

22,458

0.0323%

$517.66K

+196.9%

TANDEM DIABETES CARE INC

By person

Individual transactions

What was left out